CCN1 (cysteine-rich 61) and CCN2 (connective tissue growth factor) are growth factor-inducible immediateearly gene products found in atherosclerotic lesions, restenosed blood vessels, and healing cutaneous wounds. Both CCN proteins have been shown to support cell adhesion and induce cell migration through interaction with integrin receptors. Recently, we have identified integrin ␣ M  2 as the major adhesion receptor mediating monocyte adhesion to CCN1 and CCN2 and have shown that the ␣ M I domain binds specifically to both proteins. In the present study, we demonstrated that activated monocytes adhered to a synthetic peptide (CCN1-H2, SS-VKKYRPKYCGS) derived from a conserved region within the CCN1 C-terminal domain, and this process was blocked by the anti-␣ M monoclonal antibody 2LPM19c. Consistently, a glutathione S-transferase (GST) fusion protein containing the ␣ M I domain (GST-␣ M I) bound to immobilized CCN1-H2 as well as to the corresponding H2 sequence in CCN2 (CCN2-H2, TSVKTYRAKFCGV). By contrast, a scrambled CCN1-H2 peptide and an 18-residue peptide derived from an adjacent sequence of CCN1-H2 failed to support monocyte adhesion or ␣ M I domain binding. To confirm that the CCN1-H2 sequence within the CCN1 protein mediates ␣ M  2 interaction, we developed an anti-peptide antibody against CCN1-H2 and showed that it specifically blocked GST-␣ M I binding to intact CCN1. Collectively, these results identify the H2 sequence in CCN1 and CCN2 as a novel integrin ␣ M  2 binding motif that bears no apparent homology to any ␣ M  2 binding sequence reported to date.
CCN11 (cysteine-rich 61, CYR61) and CCN2 (connective tissue growth factor, CTGF), products of immediate-early genes transcriptionally activated in fibroblasts and smooth muscle cells upon growth factor stimulation, belong to the CCN (CYR61/CTGF/nephroblastoma-overexpressed) family of matricellular signaling molecules that have been implicated in diverse biological functions (1-3). Other CCN family members include CCN3 (nephroblastoma-overexpressed, Nov) and the wnt-1-induced secreted proteins CCN4 (WISP-1), CCN5 (WISP-2), and CCN6 (WISP-3). These conserved and modular proteins consist of an N-terminal secretory peptide followed by four structural domains that include 1) an insulin-like growth factor-binding protein homology domain, 2) a von Willebrand factor type C domain, 3) a thrombospondin type 1 repeat homology domain, and 4) a C-terminal domain with heparin binding motifs and sequence similarity to the C termini of von Willebrand factor and mucin (4). Consistent with their localization to the extracellular matrix and their homology to extracellular matrix proteins, several CCN members have been shown to support cell adhesion, induce adhesive signaling, promote cell migration, and augment growth factor-induced cell proliferation through interaction with integrin receptors and cell surface heparan sulfate proteoglycans (HSPGs) (5-13). Furthermore, both CCN1 and CCN2 induce neovascularization in the rat corneal micropocket assay (8, 9). Recentl...